Anthony Dyer

Nessuna posizione attualmente

54 anni

Consumer Services

Health Technology

Electronic Technology

Profilo

Anthony Dyer served as Director & Chief Corporate Development Officer at Novacyt SAS from 2021 to 2021.
Prior to that, he was Director at Microgen Bioproducts Ltd. from 2014 to 2021.
He will serve as CFO & Non-Executive Director at Love Hemp Group Plc from 2022 to 2023.
Dyer completed his undergraduate degree at the University of East Anglia.

Precedenti posizioni note di Anthony Dyer

Società	Posizione	Fine
Love Hemp Group Plc Love Hemp Group Plc Financial ConglomeratesFinance Invests in medical cannabis industry	Direttore Finanziario/CFO	20/01/2023
NOVACYT	Direttore Finanziario/CFO	05/01/2021
Microgen Bioproducts Ltd. Microgen Bioproducts Ltd. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and distributes diagnostic products for clinical, food, industrial veterinary and environmental testing	Direttore/Membro del Consiglio	01/04/2021

Vedi nel dettaglio l'esperienza di Anthony Dyer

Formazione di Anthony Dyer

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Anthony Dyer

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	4
University of East Anglia University of East Anglia Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Novacyt SAS Novacyt SAS Medical SpecialtiesHealth Technology Designs, develops and markets molecular real-time PCR testing devices and reagents in the areas of infectious diseases	Health Technology
Microgen Bioproducts Ltd. Microgen Bioproducts Ltd. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and distributes diagnostic products for clinical, food, industrial veterinary and environmental testing	Electronic Technology
Love Hemp Group Plc Love Hemp Group Plc Financial ConglomeratesFinance Invests in medical cannabis industry	Finance